The Application Notebook
Oxidation of amino acid residues can alter a protein's biological activity, half-life and immunogenicity. Peptide maps can be used to detect oxidized peptide fragments. Peptides are commonly separated by RP-HPLC; however, hydrophobic interaction chromatography (HIC) is an alternative technique offering different selectivity.
Oxidation of amino acid residues can alter a protein's biological activity, half-life and immunogenicity. Peptide maps can be used to detect oxidized peptide fragments. Peptides are commonly separated by RP-HPLC; however, hydrophobic interaction chromatography (HIC) is an alternative technique offering different selectivity.
In this note, we show that native Luteinizing Hormone-Releasing Hormone (LH-RH), a tryptophan (Trp)-containing peptide, is resolved from its forcibly oxidized variants using a ProPac HIC-10 column (Dionex). The separation of oxidized LH-RH revealed four peaks in addition to the two peaks from the native peptide sample. The native and oxidized LH-RH peaks were identified using mass spectroscopy.
A bioinert liquid chromatography system (Dionex ICS-3000 or UltiMate 3000 Titanium system) was used to eliminate metal complex formation or redox reactions with peptides. The LH-RH oxidization is described in Dionex Application Note 211.1
Figure 1
Figure 1(a) shows the elution of two non-oxidized LH-RH peaks from the ProPac HIC-10 column, at 11 and 18 min (peaks 5 and 6, respectively). Figure 1(b) shows four additional peaks when the Trp in LH-RH is forcibly oxidized, and the reduced peak areas for peaks 5 and 6 indicate incomplete oxidation. Four different oxidation products, hydroxy-tryptophan (HTRP), N-formylkynurenine (NFK), kynurenine (KYN) and 3-hydroxykynurenine (3OHKYN) have been described by E.L. Finley et al.2 MS analysis of the oxidized LH-RH shows the presence of four additional major ions (data not shown). MS analysis of the non-oxidized LH-RH showed a single major component with a mass-to-charge ratio equal to that expected for LH-RH. The forced oxidation peaks were identified as peptides having one of two Trp oxidation products, hydroxy-tryptophan or N-formylkynurenine (Table 1).
Table 1
The ProPac HIC-10 column can separate oxidized peptides from their native forms showing HIC to be an alternative to RP-HPLC for separation of peptide oxidation variants.
1. Dionex Corporation "Hydrophobic Interaction Chromatography for Separation of Tryptophan and Methionine Oxidized Peptides from Their Native Forms," Application Note 211, LPN 2110, Sunnyvale, California, USA. In press, 2009.
2. E.L. Finley et al., Protein Science, 7, 2391–2397 (1998).
ProPac and UltiMate are registered trademarks of Dionex Corporation.
Dionex Corporation
1228 Titan Way, PO Box 3603, Sunnyvale, California 94088, USA
tel. +1 408 737 0700 fax +1 408 730 9403
Website: www.dionex.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.